Polycystic Ovary Syndrome (PCOS) is a common hormonal disorder affecting women of reproductive age, characterized by an imbalance of reproductive hormones, leading to irregular periods, excess androgen, and often polycystic ovaries.
Ranked by community outcomes, then evidence grade, Health Voice mentions, and recency.
Why it may help PCOS: Improves metabolic and reproductive parameters
Why it may help PCOS: Zinc supplementation may reduce androgen levels and improve insulin sensitivity in women with PCOS, addressing hormonal imbalances and metabolic dysfunction central to the condition.
Inositol is a sugar alcohol involved in cell signaling, often studied for its potential role in metabolic and reproductive health, particularly in conditions like insulin resistance and PCOS.
Why it may help PCOS: Vitamin D may help PCOS by improving insulin sensitivity, reducing inflammation, and regulating hormone production, which can alleviate symptoms and improve reproductive health outcomes.
Why it may help PCOS: Cinnamon may help PCOS by improving insulin sensitivity and glucose metabolism, which can reduce hyperinsulinemia and subsequently lower androgen levels, thereby alleviating PCOS symptoms.
N-Acetyl Cysteine (NAC) is a glutathione precursor with antioxidant, anti-inflammatory, and mucolytic properties, investigated for its potential therapeutic roles in a range of health conditions.
Why it may help PCOS: Chromium may help PCOS by enhancing insulin sensitivity and glucose metabolism, which can reduce hyperinsulinemia and subsequently lower androgen levels, improving hormonal balance.
Why it may help PCOS: D-Chiro-Inositol improves insulin sensitivity in PCOS patients, thereby reducing hyperinsulinemia and subsequently lowering androgen production, which addresses a core aspect of the condition.
Why it may help PCOS: Spearmint tea may help reduce hirsutism in PCOS by decreasing free testosterone levels, as evidenced by its anti-androgenic properties observed in clinical studies.
Why it may help PCOS: Vitex (Chaste Tree) may help regulate menstrual cycles in PCOS by modulating prolactin levels and indirectly influencing gonadotropin secretion, which can improve ovulation and hormonal balance.
Why it may help PCOS: Licorice root may reduce androgen levels in women with PCOS by inhibiting 17-hydroxylase and 17,20-lyase enzymes, which are involved in androgen synthesis, thereby helping to mitigate symptoms.
Why it may help PCOS: Reduces androgens and inflammation
Why it may help PCOS: Improves insulin sensitivity and ovulation
Why it may help PCOS: Exercise may help PCOS by improving insulin sensitivity, reducing androgen levels, and promoting weight management, which collectively address key hormonal imbalances contributing to the condition.
Why it may help PCOS: Improves insulin resistance and PMS
Why it may help PCOS: Supports insulin sensitivity
Why it may help PCOS: Eases PCOS-related depression
Why it may help PCOS: Improves menstrual regularity
Why it may help PCOS: Reduces insulin resistance in PCOS
Why it may help PCOS: N-Acetyl Cysteine (NAC) improves insulin sensitivity and reduces hyperandrogenism in women with PCOS by decreasing oxidative stress and inflammation, which are implicated in the condition's pathophysiology.
Why it may help PCOS: Omega-3 fatty acids can improve insulin sensitivity and reduce inflammation in PCOS, potentially leading to better metabolic profiles and reduced androgen levels, addressing key aspects of the syndrome.
Why it may help PCOS: Turmeric may help PCOS by reducing chronic inflammation and improving insulin sensitivity, which are key factors contributing to the hormonal imbalances and metabolic dysfunction in PCOS.
Why it may help PCOS: Green Tea may help PCOS by improving insulin sensitivity, reducing androgen levels, and exerting anti-inflammatory effects, which collectively address key metabolic and hormonal aspects of the condition.
Why it may help PCOS: Magnesium supplementation may improve insulin sensitivity in women with PCOS, which can help reduce hyperinsulinemia and subsequently lower androgen levels, thereby alleviating some symptoms.
Why it may help PCOS: Chasteberry may help regulate menstrual cycles in PCOS by modulating prolactin levels and indirectly influencing gonadotropin secretion, which can improve ovulation and hormonal balance.
Why it may help PCOS: Coenzyme Q10 supplementation in PCOS may improve insulin resistance and reduce oxidative stress, contributing to better metabolic and hormonal profiles, which are often dysregulated in the condition.
Why it may help PCOS: Alpha-Lipoic Acid may help PCOS by improving insulin sensitivity and reducing oxidative stress, which are crucial for managing metabolic dysfunction and hormonal imbalances associated with the condition.
Community outcomes
Self-reported by community members · not medical advice.
Self-reported community outcomes. Not medical advice. Requires at least three reports per remedy to surface.
Community outcome data is still being collected for this ailment.
Be the first to share your experience →As more members share outcomes, RemedyAtlas will show which remedies helped people with similar conditions, symptoms, goals, and lab patterns.
Structured experience reports from people managing this condition. Not medical advice.
You can share without an account — we'll send a one-time code to verify your email. Or sign in.
Loading posts…
Community Discussions
How global health authorities view PCOS.
The World Health Organization (WHO) recognizes PCOS as a significant public health issue. Guidelines from organizations like the Endocrine Society and the American Association of Clinical Endocrinologists emphasize lifestyle modifications, including diet and exercise, as first-line management. While conventional medicine primarily focuses on pharmaceutical interventions for symptom management, there is growing interest and research into complementary approaches. The National Center for Complementary and Integrative Health (NCCIH) acknowledges that some dietary supplements and herbal remedies are being investigated for PCOS, but often notes that more rigorous research is needed to establish efficacy and safety.
Approved mentions from health educators, physicians, and researchers across podcasts, videos, and articles. Educational context only — does not influence the scientific evidence rating above.
Tallene Hacatoryan, a registered dietitian with PCOS, advocates for a holistic approach to managing the condition, focusing on diet, exercise, and community support. She developed an evidence-based method to help women lose weight, regulate symptoms, and improve confidence. Her program emphasizes dietitian-designed meal plans, PCOS-friendly workouts, and clinically-dosed supplements, aiming to empower women to manage PCOS naturally.
"Tallene Hacatoryan developed an evidence-based method for managing PCOS after her own diagnosis and experience. • The method helped her lose weight, regulate symptoms, and feel confident. • The program includes dietitian-designed meal plans, PCOS-friendly workouts, and clinically-dosed supplements. • Over 100,000 women have reportedly used The Cysterhood + OvaFit system with positive results. • The approach aims to empower women to manage PCOS naturally and reverse symptoms."
Emphasizes vitamin D repletion in PCOS, where deficiency is common and tied to insulin resistance, irregular cycles, and mood.
"Most women I work with who have PCOS are low in vitamin D — getting that level up is foundational before chasing fancier protocols."
Uses NAC to support insulin sensitivity, ovulation, and antioxidant defense in PCOS, often alongside inositol.
"NAC is a quiet workhorse for PCOS — it supports insulin sensitivity and glutathione, which most cysters are running low on."
Advocates a gluten-free, dairy-free lifestyle to reduce inflammation and androgen-driven symptoms in PCOS.
"Going gluten and dairy free was the single biggest lever for my own PCOS symptoms, and I see it transform my clients' cycles, skin, and energy."
Recommends myo-inositol (typically combined with d-chiro-inositol in a 40:1 ratio) as a first-line supplement for PCOS to improve insulin sensitivity, ovulation, and androgen balance.
"Inositol is one of the most well-studied supplements for PCOS — it helps your body use insulin more efficiently and supports more regular cycles."
Recommends NAC for PCOS to support insulin sensitivity, ovulation, and antioxidant capacity.
"NAC is one of those underrated PCOS supplements — it's in the literature for ovulation and insulin, but almost no GP mentions it."
Checks and corrects vitamin D status as a baseline step in his PCOS program.
"Before we talk fat loss or fertility with a PCOS client, we make sure vitamin D, iron, and B12 are sorted."
Promotes progressive resistance training as the highest-leverage lifestyle intervention for PCOS body composition and insulin sensitivity.
"If a woman with PCOS does one thing, lift heavy things three times a week. Cardio alone won't fix insulin resistance."
Includes inositol as a core supplement in his PCOS coaching, paired with resistance training and a lower-glycemic diet.
"Inositol plus lifting weights three times a week beats almost any "PCOS detox" protocol on Instagram — and there's actual evidence behind it."
Indexed studies for PCOS, grouped by source type and quality.
Filter by source type
Pooled analyses across multiple human trials.
Zhao G, Fan Y, Li R, Huang Y, Li W, Zhao Y · Reproductive biology and endocrinology : RB&E · 2025 · n=501
Nutritional supplements are known to ameliorate polycystic ovary syndrome (PCOS) and have been shown to modulate endocrine and metabolic markers, oxidative stress markers and inflammatory biomarkers in patients with PCOS. A variety of nutritional supplements have been applied in clinics, but a more comprehensive ranking of their efficacy has not yet been investigated. To assess the comparative effectiveness of nutritional supplements in women with PCOS. A systematic search was conducted across PubMed, EMBASE, Web of Science, and the Cochrane Library for randomized controlled trials (RCTs) that met the inclusion criteria up to October 12, 2023. We performed a network meta-analysis (NMA) to evaluate the effectiveness of various nutritional supplements on different indicators of PCOS by synthesizing both direct and indirect evidence from the trials. Seventy-nine RCTs involving 5,501 participants were enrolled in the NMA. It suggested that chromium was notably effective in improving fol
Efficacy of N-Acetylcysteine in Polycystic Ovary Syndrome: Systematic Review and Meta-Analysis.
Viña I, Viña JR, Carranza M, Mariscal G · Nutrients · 2025 · n=2515
Polycystic ovary syndrome (PCOS) is a common endocrine disorder that affects women of reproductive age and requires better treatment. N-acetylcysteine (NAC) is known to be beneficial under such conditions owing to its antioxidant potential and insulin-sensitizing properties. The effect of NAC on the reproductive outcomes of PCOS patients was examined in this meta-analysis. In accordance with PRISMA standards, this meta-analysis included studies that compared N-acetylcysteine, metformin, clomiphene citrate, and a placebo in patients with POCS. The main indicators were follicular growth, endometrial thickness, and hormone level. The risk of bias was evaluated using the Cochrane ROB2 tool. Twenty-two studies (n = 2515) were included. NAC was associated with a statistically significant increase in progesterone (SMD 0.95, 95% CI: 0.13-1.77, p = 0.02) and endometrial thickness (SMD 0.58, 95% CI: 0.10-1.06, p = 0.02) compared to the placebo and other drugs (SMD 0.71, 95% CI: 0.48-0.94, p &l
Austregésilo de Athayde De Hollanda Morais B, Martins Prizão V, de Moura de Souza M, Ximenes Mendes B, Rodrigues Defante ML, Cosendey Martins O · Journal of diabetes and its complications · 2024 · n=176
The efficacy of GLP1 receptor agonists (GLP1-RAs) in treating polycystic ovarian syndrome (PCOS) remains unclear. While GLP1-RAs are known to promote weight loss in patients with diabetes and living with obesity, their impact on weight reduction and hormonal regulation in women with PCOS is understudied. Therefore, we aimed to assess the efficacy of GLP1-RAs in PCOS women living with obesity through a meta-analysis, comparing their effects to placebo. The use of GLP1-RAs in PCOS women living with obesity can reduce body mass index and waist circumference as well as improve hyperinsulinism, and hyperandrogenism as well as normalize total testosterone, total cholesterol and HOMA-IR markers in PCOS women living with obesity. We systematically searched the PubMed, Cochrane Central, Scopus and Embase databases to identify randomized controlled trials (RCT) comparing GLP1-RAs versus placebo among women diagnosed with PCOS based on the Rotterdam Criteria. Our primary outcomes of interest in
Recommendations from medical societies (NICE, AHA, ADA, ACG, Endocrine Society…).
Recommendations from the WHO guideline for the prevention, diagnosis, and treatment of infertility.
World Health Organisation Guideline Development Group for Infertility, Mburu G, Santesso N, Brignardello-Petersen R, Kennedy R, Farquhar C · Fertility and sterility · 2026
The field of sexual and reproductive health care, including family planning has progressed in the last several decades. Significant progress has also been made in the field of medically assisted reproduction. Globally one in six people experience infertility in their lifetime. However, many countries do not include the prevention, diagnosis, and treatment of infertility in health policies, financing and services, and many do not have national clinical guidelines for the prevention, diagnosis and treatment of infertility. To determine what interventions are recommended for prevention, diagnosis and treatment of infertility among individuals and couples. The guideline was developed according to the WHO handbook for guideline development. A Guideline Development Group (GDG) was assembled and included a multidisciplinary and regionally diverse set of clinicians, policymakers, researchers, implementers and representatives of patient groups (n=30). The GDG prioritised key recommendation qu
Palomba S, Seminara G, Tomei F, Marino A, Morgante G, Baldini D · Reproductive biology and endocrinology : RB&E · 2025
The polycystic ovary syndrome (PCOS) is a multifaced disease of the reproductive age associated with several comorbidities including infertility. Very few documents regarding the management of the infertility in women with PCOS, including guidelines, position papers and consensus conferences, are available in the literature. The Italian Law indicates that health professionals must comply with the recommendations set out in the guidelines developed by public and private bodies and institutions, as well as scientific societies and technical-scientific associations of the health professions, except for specific cases. Unfortunately, no guideline for the diagnosis and the management of infertility in women with PCOS is currently available in Italy. In 2024, the Italian Society of Human Reproduction (SIRU) and the Italian Centers for the Study and Conservation of Eggs and Sperm (CECOS Italy) pointed out the need to produce Italian guidelines on this topic and established a specifi
Teede HJ, Tay CT, Laven J, Dokras A, Moran LJ, Piltonen TT · Fertility and sterility · 2023
What is the recommended assessment and management of those with polycystic ovary syndrome (PCOS), based on the best available evidence, clinical expertise, and consumer preference? International evidence-based guidelines address prioritized questions and outcomes and include 254 recommendations and practice points, to promote consistent, evidence-based care and improve the experience and health outcomes in PCOS. The 2018 International PCOS Guideline was independently evaluated as high quality and integrated multidisciplinary and consumer perspectives from six continents; it is now used in 196 countries and is widely cited. It was based on best available, but generally very low to low quality, evidence. It applied robust methodological processes and addressed shared priorities. The guideline transitioned from consensus based to evidence-based diagnostic criteria and enhanced accuracy of diagnosis, whilst promoting consistency of care. However, diagnosis is still delayed, the needs of
Cohort, case-control, and cross-sectional human studies.
Salari N, Nankali A, Ghanbari A, Jafarpour S, Ghasemi H, Dokaneheifard S · Archives of gynecology and obstetrics · 2024 · n=646
Polycystic ovary syndrome (PCOS) is the most common metabolic disorder among women of reproductive age. Many factors are involved in the development of PCOS, among which genetic predisposition is probably the main contributor that is also influenced by lifestyle and environmental factors. This study aims to determine the prevalence of PCOS in different continents based on Rotterdam, AES and NIH diagnostic criteria. We conducted a systematic review and meta-analysis to evaluate the prevalence of polycystic ovary syndrome in women according to (Preferred Reporting Items for Systematic Review and Meta-Analysis) PRISMA guidelines. PubMed, Scopus, Science Direct, Web of Science and Google Scholar databases were comprehensively searched until February 2021 for relevant articles. Heterogeneity between the studies was assessed using the I2 index. Begg and Mazumdar's test was used to evaluate publication bias. A total of 35 studies with 12,365,646 subjects were retrieved. The mean age ranged
Melin J, Forslund M, Alesi S, Piltonen T, Romualdi D, Spritzer PM · The Journal of clinical endocrinology and metabolism · 2024 · n=10
Polycystic ovary syndrome (PCOS) affects more than 1 in 10 women. As part of the 2023 International PCOS Guidelines update, comparisons between combined oral contraceptive pills (COCP), metformin, and combination treatment were evaluated. Ovid Medline, Embase, PsycINFO, All EBM, and CINAHL were searched. Women with PCOS included in randomized controlled trials (RCTs). We calculated mean differences and 95% CIs regarding anthropometrics, metabolic, and hyperandrogenic outcomes. Meta-analyses and quality assessment using GRADE were performed. The search identified 1660 publications; 36 RCTs were included. For hirsutism, no differences were seen when comparing metformin vs COCP, nor when comparing COCP vs combination treatment with metformin and COCP. Metformin was inferior on free androgen index (FAI) (7.08; 95% CI 4.81, 9.36), sex hormone binding globulin (SHBG) (-118.61 nmol/L; 95% CI -174.46, -62.75) and testosterone (0.48 nmol/L; 95% CI 0.32, 0.64) compared with COCP. COCP was i
van der Ham K, Laven JSE, Tay CT, Mousa A, Teede H, Louwers YV · Fertility and sterility · 2024 · n=68
As part of the 2023 international evidence-based polycystic ovary syndrome (PCOS) guideline, this meta-analysis investigated the inclusion of Anti-Müllerian hormone (AMH) levels in the diagnostic criteria for PCOS. To answer the following three questions: 1) Are AMH levels effective in diagnosing PCOS in adult women? 2) Are AMH levels effective in diagnosing PCOS in adolescents? Are AMH levels effective in diagnosing polycystic ovarian morphology (PCOM)? Searches were conducted in six databases until July 31, 2023. Eligible studies were those conducted in humans, published in English, and reporting sensitivity, specificity, and/or area under the curve values. Extracted data included study population, age, body mass index, AMH assay, cut-off value of AMH levels, sensitivity, specificity, and area under the curve values. The risk of bias was assessed using the quality assessment of diagnostic accuracy studies tool. A random effects model was used to test diagnostic accuracy.
Public-health agencies: NCCIH, NIH, CDC, NHS.
Polycystic Ovary Syndrome (PCOS)
ACOG
ACOG provides patient-focused information on PCOS, covering symptoms, diagnosis, treatment, and lifestyle management strategies. While a patient FAQ, it reflects clinical consensus for women's health.
NHS
The NHS website offers information on Polycystic Ovary Syndrome (PCOS), detailing symptoms, causes, diagnosis, and treatment options. It serves as a public health resource for understanding the condition.
Registered ongoing or completed trials (ClinicalTrials.gov).
n=200 · NCT01896492 · COMPLETED · COMPLETED
Polycystic ovary syndrome (PCOS) is one of the most common endocrine disorders, affecting approximately 6-10% of women of reproductive age. Anovulation, infertility and hyperandrogenism often co-exist with hyperinsulinaemia and insulin resistance . Clomiphene citrate remains the standard drug for induction or augmentation of ovulation. However, it is not equally effective in all situations, and therefore it may require additional expensive drugs such as N-acetyl cysteine, as an antioxidant, has been suggested as an adjuvant in clomiphene-resistant cases .NAC may also improve the circulating level of insulin and insulin sensitivity in hyperinsulinaemic women with PCOS, and may be useful for the treatment of insulin resistance by ameliorating the homocysteine and lipid profile in PCOS .
n=30 · NCT07616037 · RECRUITING · RECRUITING
Polycystic ovary syndrome (PCOS) is the most common reproductive endocrine and metabolic disorder among women of reproductive age. It is characterized by oligo-ovulation or anovulation, clinical and/or biochemical hyperandrogenism, and polycystic ovarian morphology. In addition, PCOS is frequently accompanied by multiple metabolic abnormalities, including insulin resistance, obesity, impaired glucose tolerance, and dyslipidemia. Clinical studies have demonstrated that treatment with glucagon-like peptide-1 receptor agonists (GLP-1RAs) in women with PCOS results in significant weight reduction, decreased free testosterone levels, improvement in menstrual regularity, and increased clinical pregnancy rates. Fibroblast growth factor 21 (FGF21) has been shown to enhance insulin sensitivity, promote fatty acid oxidation, and improve lipid distribution. HEC88473 is a novel long-acting dual agonist targeting both the glucagon-like peptide-1 (GLP-1) receptor and the fibroblast growth factor 21 (FGF21) receptor. This study is initiated to evaluate the clinical efficacy of HEC88473 in women with PCOS and to explore its potential as a new therapeutic option for the management of PCOS.
n=32 · NCT04723862 · RECRUITING · RECRUITING
The purpose of this study is to determine if, in mid- to late pubertal girls with hyperandrogenism (HA), androgen-receptor blockade (spironolactone) alone normalizes sleep-wake luteinizing hormone (LH) pulse frequency (primary endpoint) and overall LH and follicle-stimulating hormone secretion (secondary endpoints).
Curated cross-source summaries (TRIP Database and similar).
Cochrane
Cochrane provides a collection of systematic reviews and meta-analyses related to PCOS, offering high-level evidence on various interventions and diagnostic approaches.
Cochrane Library: Search result for Polycystic Ovary Syndrome
Cochrane
The Cochrane Library provides high-quality, independent evidence to inform healthcare decision-making, offering systematic reviews related to various aspects of PCOS.
Cochrane
The Cochrane Library provides a collection of systematic reviews and meta-analyses related to Polycystic Ovary Syndrome. It offers high-quality, evidence-based summaries of research to inform healthcare decisions.
Conventional medical care for PCOS often involves medications to manage symptoms, such as oral contraceptives for menstrual regulation and androgen reduction, metformin for insulin resistance, and anti-androgen drugs for hirsutism and acne. Fertility treatments may also be offered. Regular monitoring for associated health risks like type 2 diabetes and cardiovascular disease is also a key componen
Latest News
Health Videos
This information is for educational purposes only and not a substitute for professional medical advice. PCOS management should be individualized and supervised by a qualified healthcare provider. Always consult with your doctor before starting any new treatment, supplement, or making significant die
Found something that helped your pcos?
Help others see what actually works.
Found something that helped your pcos?
Real-world results help others choose what's worth trying.